Large-scale testing (Phase 3)Looking for participantsNCT03126916
What this trial is testing
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Who this might be right for
GanglioneuroblastomaGanglioneuroblastoma, NodularNeuroblastoma
Children's Oncology Group 750